CERT - Certara, Inc.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.
As of May 15, 2026: spot at $4.47, ATM IV 121.7%, net GEX $104.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Market Cap
- $745.2M
- Beta
- 1.53
- 52-Week Range
- 4.775-13.88
- CEO
- Jon Resnick
- Employees
- 1,487
- IPO Date
- Dec 11, 2020
- Exchange
- NASDAQ
What CERT Looks Like to Options Traders Today
IV rank of 22.0% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($104) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes.
What This Page Covers
The CERT overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked CERT overview questions
- What is CERT?
- CERT is the ticker symbol for Certara, Inc., a listed security. Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Listed on NASDAQ. CERT is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the CERT options snapshot look like today?
- As of May 15, 2026, the CERT options snapshot shows spot at $4.47, ATM IV 121.7%, IV rank 22.0%, net GEX $104, expected move 34.89%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are CERT's key statistics?
- Certara, Inc. (CERT) carries a market capitalization of $745.2M, beta of 1.53 relative to the broader market, 52-week range of 4.775-13.88. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does CERT belong to?
- Certara, Inc. operates in the Healthcare sector, in the Medical - Healthcare Information Services industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare CERT's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the CERT data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).